跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
VIPROZ TONGKAT ALI PLUS CAPSULE - NPRA Drug Approval Details
Approvals
/
NPRA
/
VIPROZ TONGKAT ALI PLUS CAPSULE
Approved
STANDARD
VIPROZ TONGKAT ALI PLUS CAPSULE
TAISHIN GROUP SDN. BHD.
🇲🇾 National Pharmaceutical Regulatory Agency
Approval Date
Apr 23, 2026
Approval ID
4bdbc6a5dcacb734
Company
TAISHIN GROUP SDN. BHD.
Type
Standard
Approval Details
Approval Id
4bdbc6a5dcacb734
Drug Approval Npra Name
VIPROZ TONGKAT ALI PLUS CAPSULE
Product Name
VIPROZ TONGKAT ALI PLUS CAPSULE
Registration Number
MAL26046012TC
Holder Company Name
TAISHIN GROUP SDN. BHD.
Holder Address
C-01-01, BLOCK C, SUNWAY GIZA MALL, NO.2, JALAN PJU 5/14, KOTA DAMANSARA, 47810 PETALING JAYA MALAYSIA
Holder Phone
0172103615
Manufacturer Company Name
KENSHIN BIOLABS SDN. BHD.
Manufacturer Address
NO. 35 & 37, JALAN SC 3 PUSAT PERINDUSTRIAN SUNGAI CHUA 43000 KAJANG MALAYSIA
Source Url
https://quest3plus.bpfk.gov.my/pmo2/detail.php?type=product&id=MAL26046012TC
Version
1776971413
Approved
Quick Info
Agency
NPRA
Country
🇲🇾
Approval Date
Apr 23, 2026
Approval ID
4bdbc6a5dcacb734
Type
Standard
Source
Official Source
Back to NPRA Approvals